We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

17 hedge funds and large institutions have $2.69M invested in Minerva Neurosciences in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.91% less ownership

Funds ownership: 32.39% → 31.48% (-0.91%)

2% less capital invested

Capital invested by funds: $2.75M → $2.69M (-$61.2K)

11% less funds holding

Funds holding: 19 → 17 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$1.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.03K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$364
4
Wells Fargo
Wells Fargo
California
+$2

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$46K
2
BCM
Bridgeway Capital Management
Texas
-$24.5K
3
Group One Trading
Group One Trading
Illinois
-$9.2K
4
Morgan Stanley
Morgan Stanley
New York
-$207
5
Bank of America
Bank of America
North Carolina
-$10
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$1.92M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$310K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$177K +$1.03K +500 +0.5%
BlackRock
4
BlackRock
New York
$126K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$65.7K – – –
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$44K – – –
State Street
7
State Street
Massachusetts
$21.9K – – –
Morgan Stanley
8
Morgan Stanley
New York
$13.7K -$207 -100 -1%
Wells Fargo
9
Wells Fargo
California
$3.16K +$2 +1 +0.1%
Russell Investments Group
10
Russell Investments Group
United Kingdom
$1.88K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$1K +$1.7K +822 New
TFM
12
TFC Financial Management
Massachusetts
$298 – – –
BAM
13
Belpointe Asset Management
Nevada
$160 – – –
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$160 – – –
AIM
15
Anchor Investment Management
South Carolina
$19 – – –
Millennium Management
16
Millennium Management
New York
– -$46K -28,881 Closed
BCM
17
Bridgeway Capital Management
Texas
– -$24.5K -15,436 Closed
Group One Trading
18
Group One Trading
Illinois
– -$9.2K -5,785 Closed
Bank of America
19
Bank of America
North Carolina
– -$10 -6 Closed
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$364 +176 New

NERV Hedge Fund Activity: Q1 2023 in Review

17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2023, worth a combined $2.69M — down 2.2% from $2.75M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NERV and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $1.7K. The largest seller was Millennium Management, exiting entirely with an estimated $46K sold.

  • 17 institutional investors held Minerva Neurosciences (NERV) as of Q1 2023, down from 19 in Q4 2022.
  • Funds reported $2.69M of Minerva Neurosciences stock for Q1 2023, down 2.2% quarter-over-quarter.
  • 2 funds opened new Minerva Neurosciences positions in Q1 2023 and 4 closed out, a net change of -2 holders.
  • The largest Minerva Neurosciences buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $1.7K added.
  • The largest Minerva Neurosciences seller in Q1 2023 was Millennium Management, an estimated $46K sold.

Based on aggregated 13F filings for Q1 2023.